TrialPharmacology research & perspectives2019

Phase I study of PF‐04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis.

Michael D Aleo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.